2023
3 Rivers Biotech Discovers Hop Latent Viroid (HLVd) in Recirculated Water and Work Surfaces
3 Rivers Biotech Discovers Hop Latent Viroid (HLVd) in Recirculated Water and Work Surfaces
2023
3 Rivers Biotech Identifies Root Tissue from Mature Plants as the Most Reliable to Detect Hop Latent Viroid (HLVd)
For detecting Hop Latent Viroid (HLVd), study results indicate root tissue as the best sample type. Mature plants are better than young plants for detection.
2022
3 RIVERS BIOTECH IDENTIFIES ROOT APHIDS AS POTENTIAL VECTOR FOR HOP LATENT VIROID (HLVd)
3 Rivers Biotech, a leading plant tissue culture company, today announced it has identified Root Aphids as a potential vector for Hop Latent Viroid (“HLVd”). In a controlled study, the 3 Rivers team found a potentially strong correlation between the presence of Aphids and HLVd transmission.
2021
3 Rivers Appoints Award-Winning Phytopathologist Prof. Dr. Zamir Punja to its Advisory Board
3 Rivers Biotech (“3 Rivers“ or the “Company”), a leader in plant tissue culture propagation, pathogen testing and genetic fingerprinting in the cannabis, hemp and traditional agriculture sectors, is pleased to announce that it has appointed Prof. Dr. Zamir Punja to its Advisory Board.
2021
Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. (“3 Rivers”), a leading agricultural technology company specialized in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp and traditional crops.
2021
3 Rivers Biotech’s Genie Lab Now Open for Business
3 Rivers Biotech today announced the opening of its Genetic Centre of Excellence (“Genie Lab”). This facility provides genetic fingerprinting, as well as tests for pathogenic viruses and fungi specific to cannabis and hemp.
2020
CTT Enters into Business Development Partnership with 3 Rivers Biotech
3 Rivers will leverage its network of suppliers to and manufacturers of Consumer Packaged Goods (CPG) to secure commercial partnerships based on CTT’s patented sublingual wafer technology
2020
3 Rivers Finalizes Agreement with The Hemp Mine to Distribute Proven Hemp Varieties
3 Rivers will sell tissue culture clones derived from Hemp Mine’s premium hemp varieties to licensed growers across the United States and globall
2020
3 Rivers Biotech Enters into Agreement with Cheyenne Mountain Seeds
3 Rivers will initiate two of Cheyenne’s top performing varieties, Mountain Mango and Quick Kush, into tissue culture for the purposes of manufacturing and selling micropropagated hemp plants to licensed growers across the United States
2020
3 Rivers Biotech Enters into Agreement to Distribute Elite Hemp Varieties from Trilogene Seeds
Under the terms of the agreement 3 Rivers will initiate, micropropagate, and sell some of Trilogene’s premium hemp varieties to licensed growers across the United States